LOH analysis should not be used as a tool to assess whether UVs of BRCA1/2 are pathogenic or not
- PMID: 20054658
- DOI: 10.1007/s10689-009-9318-9
LOH analysis should not be used as a tool to assess whether UVs of BRCA1/2 are pathogenic or not
Comment on
-
Methylation not a frequent "second hit" in tumors with germline BRCA mutations.Fam Cancer. 2009;8(4):339-46. doi: 10.1007/s10689-009-9240-1. Epub 2009 Apr 2. Fam Cancer. 2009. PMID: 19340607
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
